S Bruno, T Stroffolini, M Colombo, S Bollani, … - HEPATOLOGY-BALTIMORE THEN ORLANDO-, 2007 - interscience.wiley.com This study has been presented in part at the 56th Annual Meeting of the American
Association for the Study of the Liver Diseases, San Francisco, CA, November
11-15, 2005. Potential conflict of interest: Nothing to report. § fax: ... Cited by 96 - Related articles - BL Direct - All 3 versions
SM Lin, ML Yu, CM Lee, RN Chien, IS Sheen, … - Journal of hepatology, 2007 - Elsevier The cumulative incidence at the end of 15 years of follow-up (median 6.8 years,
range 1.1–16.5 years) in the IFN-treated patients and controls was: HBeAg
seroconversion 74.6% vs. 51.7% (P = 0.031); hepatitis B surface antigen ... Cited by 76 - Related articles - All 10 versions
- ►annals.org [PDF] BJ Veldt, EJ Heathcote, H Wedemeyer, J … - Annals of Internal Medicine, 2007 - Am Coll Physicians Background: Clinical outcomes of chronic hepatitis C infection in patients with
advanced fibrosis include liver failure, hepatocellular carcinoma, and death. ... Objective: To investigate whether sustained virologic response to ... Cited by 67 - Related articles - BL Direct - All 5 versions
N Merchante, JA Girón-González, M González- … - Aids, 2006 - journals.lww.com Results: Ninety-five (62%) patients died during the follow-up. In 79 (85%)
individuals, the cause of death was liver related. The median survival time was
13 months. Independent predictors of survival were Child score [hazard ... Cited by 59 - Related articles - BL Direct - All 3 versions
JA Pineda, JA Garcia-Garcia, M Aguilar- … - Hepatology, 2007 - interscience.wiley.com Little is known about the natural history of liver disease in human
immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected subjects under
highly active antiretroviral therapy (HAART). The objectives of this study ... Cited by 41 - Related articles - BL Direct - All 3 versions
S Bruno, A Crosignani, P Maisonneuve, S … - Hepatology, 2007 - interscience.wiley.com Hepatocellular carcinoma (HCC) is the most frequent cause of death in patients
with hepatitis C virus (HCV)-induced cirrhosis. Despite a number of studies in
different populations worldwide suggesting an association between HCV ... Cited by 38 - Related articles - BL Direct - All 4 versions
SA Harrison - Journal of clinical gastroenterology, 2006 - journals.lww.com Abstract: Diabetes mellitus is a growing health concern in our so- ciety. In
addition to the well-known cardiovascular, renal, and oph- thalmologic
complications of diabetes, liver-related complications occur commonly and ... Cited by 33 - Related articles - BL Direct - All 4 versions
M Yu, SM Lin, WL Chuang, CY Dai, JH Wang, … - Antiviral Therapy, 2006 - intmedpress.com Background: The long-term benefit for chronic hepatitis C (CHC) patients treated
with interferon (IFN)/ribavirin (RBV) combination therapy remains unclear. We
aimed to evaluate the long-term effects of IFN monotherapy and IFN/RBV ... Cited by 21 - Related articles - BL Direct - All 4 versions
M Omata, H Yoshida, Y Shiratori - Clinical Gastroenterology and Hepatology, 2005 - Elsevier Chronic hepatitis C is a leading cause of hepatocellular carcinoma (HCC)
worldwide. Prevention of chronic hepatitis C–related HCC is one of the most
important issues in current hepatology. We conducted 2 cohort studies, one ... Cited by 23 - Related articles - All 8 versions
